Apnimed Provides Clinical Updates for Multiple Product Candidates
Hand-out
Press Releases
April 7, 2025

Apnimed Provides Clinical Updates for Multiple Product Candidates

First Patient Dosed in Phase 2A Dose-Finding, Proof-of-Concept RESTEADY Trial Evaluating SASS-001 in a Sub-Population of Patients with Sleep Apnea with a Central Component; Top-line Data Expected in 1H 2026SASS-001,

bradford

The Bradford Era

Local & Social